48 completed. 48 Phase 2, 7 Phase 3, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 48 | Completed 48 |
| Phase 3 | 7 | Completed 7 |
| Phase 1 | 6 | Completed 6 |
Follow Fish Oils: new trials by email Literature Review of Fish Oils trials Research Report on Fish Oils
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| the Effects of Fish Oil Supplements on Choroidal Thickness and Blood Flow Perfusion in Children and Adolescents fish oil - Fish Oils | Phase 2 | Completed | Shanghai Eye Disease Prevention and Treatment Center | 38 | 2024-07-21 | 2025-03-14 |
| Supplements, Placebo, or Rosuvastatin Study Fish Oil, Cinnamon, Garlique,Turmeric, Plant Sterol, Red Yeast Rice, Rosuvastatin, Placebo - Hypercholesterolemia | Phase 2 | Completed | The Cleveland Clinic | 203 | 2021-04-23 | 2023-05-25 |
| A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) ORMD-0801 (Insulin) capsule 8 mg BD, Placebo - Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis | Phase 2 | Completed | Oramed, Ltd. | 32 | 2020-11-24 | 2024-08-07 |
| A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus ORMD-0801, Placebo - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Oramed, Ltd. | 49 | 2020-11-23 | 2024-05-07 |
| Omega-3 Fatty Acids for Smoking Cessation in Pregnancy Fish Oil (Containing Omega-3 Acids), Olive Oil - Preterm Labor, Tobacco Use Disorder | Phase 2 | Completed | Vanderbilt University Medical Center | 237 | 2020-11-10 | 2026-06-04 |
| A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus Cohort A: ORMD-0801, Placebo oral capsule, Cohort B: ORMD-0801 - T2DM (Type 2 Diabetes Mellitus) | Phase 2 | Completed | Oramed, Ltd. | 373 | 2018-05-29 | 2022-11-08 |
| Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults control fish oil, LCMUFA-rich saury oil - Lipoprotein Metabolism, PCSK9 | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 37 | 2017-06-15 | 2020-08-12 |
| Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis Omega-3 polyunsaturated fatty acids, Aspirin, Placebo - Aggressive Periodontitis | Phase 2 / Phase 3 | Completed | Universidade Estadual Paulista Júlio de Mesquita Filho | 38 | 2017-05-15 | 2021-12-28 |
| Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis Open flap debridement, Placebo, Omega-3 polyunsaturated fatty acids - Residual Disease, Aggressive Periodontitis | Phase 2 / Phase 3 | Completed | Universidade Estadual Paulista Júlio de Mesquita Filho | 34 | 2017-05-15 | 2020-11-17 |
| Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study Fish oil, Placebos - Tobacco Use in Childbirth, Smoking Cessation | Phase 2 | Completed | Vanderbilt University Medical Center | 28 | 2017-03-02 | 2019-01-09 |
| A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus ORMD-0801 (qd), ORMD-0801 (bid), ORMD-0801 (tid) - Type 2 Diabetes Mellitus | Phase 2 | Completed | Oramed, Ltd. | 31 | 2016-10-01 | 2018-07-12 |
| The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study Omega-3 fish oil, Losartan, Corn Oil (Fish oil Placebo) - Inflammation | Phase 2 | Completed | University of Florida | 289 | 2016-04-26 | 2024-05-07 |
| A Comparator Trial on the Relative Efficacy of Two Triglyceride Forms of Fish Oil Fish Oil - Healthy Volunteers | Phase 2 | Completed | Nordic Pharma, USA | 60 | 2016-02-01 | 2016-12-14 |
| Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults EPA-rich fish oil, DHA-rich fish oil - Lipoprotein Metabolism, PCSK9 | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 44 | 2015-10-30 | 2021-07-15 |
| Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients Fingolimod, Fish Oil, Placebo (for Fish Oil) - Multiple Sclerosis | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 50 | 2015-04-01 | 2019-05-14 |
| Intervention With Omega Fatty Acids in High-risk Patients Omega-3 Fatty Acid, Omega-6 Fatty Acid - Cardiovascular Disease | Phase 2 | Completed | Haukeland University Hospital | 40 | 2015-03-01 | 2016-12-20 |
| Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis lipoic acid and omega-3 fatty acids, Placebo - Multiple Sclerosis, Cognition | Phase 1 / Phase 2 | Completed | Oregon Health and Science University | 54 | 2014-06-01 | 2017-06-02 |
| A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics ORMD-0801 Capsules, Placebo - Diabetes Mellitus Type 1 | Phase 2 | Completed | Oramed, Ltd. | 25 | 2014-03-01 | 2017-07-06 |
| Bioavailability of Fatty Acids From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects. Krill oil, Krill meal, Fish oil - Healthy | Phase 2 | Completed | Olympic Seafood AS | 19 | 2014-02-01 | 2014-06-04 |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer omega-3 fatty acid, placebo, laboratory biomarker analysis - Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ | Phase 2 | Completed | Wake Forest University Health Sciences | 57 | 2013-11-01 | 2019-10-30 |
Showing 20 of 48. Sign in to see all of them.
Diabetes Mellitus, Type 2 (6) · Inflammation (6) · Cardiovascular Diseases (4) · Non-alcoholic Fatty Liver Disease (4) · Fatty Liver (3) · Hypertriglyceridemia (3) · Aggressive Periodontitis (2) · Alzheimer Disease (2) · Breast Neoplasms (2) · Carcinoma, Intraductal, Noninfiltrating (2) · Depressive Disorder, Major (2) · Insulin Resistance (2) · Metabolic Syndrome (2) · Multiple Sclerosis (2) · Acute Lung Injury (1)
Oramed, Ltd. (5) · Oregon Health and Science University (4) · Icahn School of Medicine at Mount Sinai (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Universidade Estadual Paulista Júlio de Mesquita Filho (2) · University of Cincinnati (2) · University of Rochester (2) · Vanderbilt University Medical Center (2) · Wake Forest University Health Sciences (2) · Andrea Bonny (1) · Charite University, Berlin, Germany (1) · Haukeland University Hospital (1) · Isfahan University of Medical Sciences (1) · Johann Wolfgang Goethe University Hospital (1) · National Center for Complementary and Integrative Health (NCCIH) (1)
United States (36) · Canada (4) · Brazil (2) · China (1) · Egypt (1) · Finland (1) · Israel (1) · Russia (1)
Joel M Neutel, M. D. (4) · Lynne Shinto, ND, MPH (3) · Marcelo J Amar, M.D. (2) · Mauro Santamaria, Professor (2) · Miriam Kidron, Ph.D. (2) · Robert C Block, MD, MPH (2) · Robert McNamara, PhD (2) · Vilma Gabbay, M.D. (2) · Alp Ikizler, MD (1) · Amr M. Elkhouli, ph.D (1) · Andrea Bonny, MD (1) · Anthony Bier, MD (1) · Arthur J. McCullough, M.D. (1) · Christopher M DeGiorgio, MD (1) · Cristina G Arriens, MD (1)
PMID 17971707, PMID 20667792, PMID 20980771, PMID 21816071, PMID 22136963, PMID 22640930, PMID 23010452, PMID 23453547, PMID 23664596, PMID 23702094, PMID 24077434, PMID 24373610, PMID 24583757, PMID 25195547, PMID 25201887, PMID 25264972, PMID 25393536, PMID 25515553, PMID 25555354, PMID 25771388, PMID 25884846, PMID 26283629, PMID 26696953, PMID 29985566, PMID 30541065, PMID 33875799, PMID 33933722, PMID 34906201, PMID 36351465, PMID 37404855, PMID 39131144
M01RR000334 (1), P30CA012197 (1), R01AG029562 (1), R01HD098719 (1), R21AG023805 (1), R21AT002395 (1), R21AT002901 (1), R21AT003844 (1), R21AT004576 (1), U01AG050499 (1), U01DK061732 (1)